Mkt Cap
₹1.27 L Cr.
P/E (TTM)
60.90
Open
₹8,806.00
Day's Range
₹8,806.00 – ₹8,950.00
52W Range
₹6,696.50 – ₹9,050.00
Div Yield
0.23%
EPS (TTM)
₹40.39
Book Value
₹693.71

APOLLO HOSPITALS ENTER L Quarterly Results

In Jun 2026, APOLLO HOSPITALS ENTER L reported revenue of ₹7,044 crore (up 6.6% on the prior quarter) and net profit of ₹581 crore (up 9.7%). 29 reported quarters are tabulated below.

Updated Source: NSE & BSE company filingsNifty 50 constituent
Latest quarter revenue
₹7,044 Cr
+6.6% vs prior
EBITDA
₹1,092 Cr
+8.0% vs prior
Operating margin
15.51%
Profit after tax
₹581 Cr
+9.7% vs prior
Net margin
8.24%
EPS
₹40.39
Latest quarter
Jun 2026
Quarters reported
29

APOLLO HOSPITALS ENTER L revenue and profit trend

The quickest view of reported quarterly business performance. Revenue and profit use separate scales.

APOLLO HOSPITALS ENTER L quarterly results

Reported quarterly performance for APOLLO HOSPITALS ENTER L, oldest to newest. Figures in ₹ crore unless a row states otherwise.

APOLLO HOSPITALS ENTER L quarterly profit and loss statement. Figures in ₹ crore unless a row states otherwise.
Line itemSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue from Operations4,8474,8514,9445,0865,5895,5275,5925,8426,3046,4776,6067,044
Sales Growth YoY %14.02%13.77%14.92%15.12%15.32%13.94%13.11%14.88%12.78%17.2%18.12%20.56%
Other Income222828373864614055534449
Total Income4,8694,8784,9725,1235,6285,5915,6535,8826,3586,5306,6497,092
Cost of Goods Sold (COGS)2,4592,5332,5462,6232,8582,9012,9293,0483,2443,3823,4023,597
Cost of Materials Consumed633603638690744626694740779745777829
Purchases of Stock-in-Trade1,8411,9441,9141,9112,1102,2922,2442,3162,4652,6632,6132,768
Changes in Inventories-15-14-6223-17-9-80-25120
Gross Profit2,3882,3182,3982,4632,7322,6262,6642,7953,0603,0953,2043,446
Gross Margin %49.28%47.78%48.51%48.42%48.87%47.52%47.63%47.83%48.54%47.78%48.5%48.93%
Total Operating Expenses1,7611,7041,7581,7881,9161,8651,8941,9432,1192,1302,1932,354
Employee Benefit Expense644613645658700686725713767749772796
Other Expenses1,1171,0911,1131,1291,2161,1781,1691,2301,3521,3811,4211,559
EBITDA6286146416758167627708529419651,0111,092
OPM %12.95%12.65%12.96%13.27%14.59%13.78%13.76%14.58%14.93%14.9%15.31%15.51%
Total Non-Operating Expenses277280309294302294326323327313344356
Depreciation & Amortisation163167190177185185211215218219224235
Finance Costs111113119116118110115108110113119120
Exceptional Items (Before Tax)200000000-1900
Profit Before Tax (PBT)377362360419552531505569668667711785
Tax Expense130109110115162157101142181166170188
Current Tax13311389113160135119125162147196210
Deferred Tax-2-4212222-18171919-26-22
Effective Tax %34.54%30.09%30.53%27.36%29.31%29.53%20%24.9%27.03%24.84%23.92%23.99%
Total Profit for Period249254258316396379415441494516551610
Less: Non-controlling Interests16951017725817142230
Net Profit (Owner's PAT)233245254305379372390433477502529581
Net Profit Margin %4.81%5.06%5.13%6%6.78%6.74%6.97%7.41%7.57%7.75%8.01%8.24%
PAT Growth YoY %14.17%59.85%75.62%83.19%62.64%51.77%53.51%41.81%25.98%34.92%35.86%34.17%
Earnings Per Share (EPS)₹16.2₹17.06₹17.65₹21.23₹26.34₹25.89₹27.1₹30.1₹33.19₹34.93₹36.81₹40.39
Diluted Shares Outstanding (Cr.)141414141414141414141414
Profit/Loss from Associates219126511146151013
Other Comprehensive Income (Net of Tax)-91-05-6-3-3657-0-44
Expenses4,4924,5174,6124,7045,0765,0605,1485,3135,6905,8635,9386,307
Material Cost %13.05%12.44%12.89%13.57%13.32%11.32%12.42%12.67%12.35%11.5%11.77%11.77%
Employee Cost %13.29%12.64%13.04%12.94%12.53%12.42%12.96%12.2%12.16%11.56%11.69%11.3%
Other Cost %23.04%22.49%22.51%22.21%21.76%21.32%20.91%21.05%21.45%21.32%21.5%22.13%
Interest Coverage (x)4.173.973.784.285.375.254.875.886.66.636.67.12

Showing the most recent 12 of 29 reported periods.

How this is calculated

Figures are as reported to NSE/BSE by the company. Consolidated is shown where the company reports it, standalone otherwise; the basis is labelled on the table. Growth is computed against the same quarter of the previous year (YoY) and the immediately preceding quarter (QoQ).

Index membership reflects the Nifty 100 as published by NSE Indices, effective 2026-03-30.

APOLLO HOSPITALS ENTER L: frequently asked questions

What was APOLLO HOSPITALS ENTER L's revenue in Jun 2026?

APOLLO HOSPITALS ENTER L reported revenue of ₹7,044 crore in Jun 2026, up 6.6% on the previous quarter.

What was APOLLO HOSPITALS ENTER L's profit in Jun 2026?

APOLLO HOSPITALS ENTER L reported a net profit of ₹581 crore in Jun 2026, up 9.7% on the previous quarter.

What is APOLLO HOSPITALS ENTER L's EPS?

APOLLO HOSPITALS ENTER L reported earnings per share of ₹40.39 for Jun 2026.

What is APOLLO HOSPITALS ENTER L's operating margin?

APOLLO HOSPITALS ENTER L's operating margin for Jun 2026 was 15.51%.

When did APOLLO HOSPITALS ENTER L last report results?

The most recent reported quarter shown here is Jun 2026. 29 quarters of history are tabulated on this page.

Are these figures consolidated or standalone?

Consolidated figures are shown wherever the company reports them, and standalone otherwise. The basis in use is labelled on the statement table.

Comparing quarterly results across companies is more useful than reading one in isolation — the peer links above open the same view for APOLLO HOSPITALS ENTER L’s closest listed competitors.

Disclaimer

The data, ratios and commentary about APOLLO HOSPITALS ENTER. L (APOLLOHOSP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.